Gilenya Approved for Multiple Sclerosis
Links shared publicly online about this topic
Gilenya approved for multiple sclerosis - ONA
oncologynurseadvisor.com — “The FDA has approved Gilenya (fingolimod capsules, from Novartis), a sphingosine 1-phosphate receptor modulator indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.” View full resource at oncologynurseadvisor.com
Most Recently Shared on September 22, 2010 at 2:55 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Gilenya approved for multiple sclerosis http://goo.gl/fb/E9hlT
Gilenya approved for multiple sclerosis - MPR
empr.com — “The FDA has approved Gilenya (fingolimod capsules, from Novartis), a sphingosine 1-phosphate receptor modulator indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.” View full resource at empr.com
Most Recently Shared on September 22, 2010 at 2:07 pm By:
MPR News: Gilenya approved for multiple sclerosis: The FDA has approved Gilenya (fingolimod capsules, from Novarti... http://bit.ly/bNY0nL
Multiple Sclerosis Drug Gilenya (Fingolimod) Approved By FDA
medicalnewstoday.com — “Gilenya (fingolimod) 0.5 mg daily for the treatment of relapsing forms of multiple sclerosis has been approved by the Food and Drug Administration. Swiss pharmaceutical company, Novartis, says tha” View full resource at medicalnewstoday.com
Most Recently Shared on September 22, 2010 at 6:37 pm By:
Multiple Sclerosis Drug Gilenya (Fingolimod) Approved By FDA Gilenya (fingolimod) 0.5 mg daily for the treatment of rel.. http://dld.bz/wCXT
Gilenya Approved for Relapsing MS
everydayhealth.com — “Oral drug designed to slow progressive disability” View full resource at everydayhealth.com
Most Recently Shared on September 23, 2010 at 12:30 am By:
New drug approved by #FDA for relapsing MS http://ow.ly/2IkkJ #multiplesclerosis
Multiple Sclerosis Drug Gilenya Approved in Russia | ThirdAge
thirdage.com — “The Multiple Sclerosis drug, Gilenya, manufactured by Novartis has been approved for use in Russia. The drug is a daily oral therapy for treating relapses of multiple sclerosis. Russia is the first country to approve the use of the drug for treating MS.” View full resource at thirdage.com
Most Recently Shared on September 16, 2010 at 1:28 am By:
Multiple Sclerosis Drug Gilenya Approved in Russia: The Multiple Sclerosis drug, Gilenya, manufactured by Novartis... http://bit.ly/buTAb7
Multiple Sclerosis Drug Gilenya Approved in Russia | ThirdAge
thirdage.com — “The Multiple Sclerosis drug, Gilenya, manufactured by Novartis has been approved for use in Russia. The drug is a daily oral therapy for treating relapses of multiple sclerosis. Russia is the first country to approve the use of the drug for treating MS.” View full resource at thirdage.com
Most Recently Shared on September 15, 2010 at 11:26 pm By:
Multiple Sclerosis Drug Gilenya Approved in Russia http://bit.ly/b5Wg6T
Gilenya Approved for Relapsing MS --Doctors Lounge
doctorslounge.com — “Gilenya Approved for Relapsing MS --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on September 22, 2010 at 11:53 pm By:
Gilenya Approved for Relapsing MS: Oral drug designed to slow progressive disability http://bit.ly/cikQYP
Novartis's Gilenya Multiple Sclerosis Pill Wins European Agency's Backing - Bloomberg
bloomberg.com — “Novartis AG won European Union regulatory backing for its multiple sclerosis drug Gilenya, beating Merck KGaA in a race to sell a pill to slow the crippling disease.” View full resource at bloomberg.com
Most Recently Shared on January 21, 2011 at 12:09 pm By:
John Carroll Health Communicator
Novartis' competing MS pill Gilenya wins European approval. Cladribine slips further behind. http://bloom.bg/guoaZL
Multiple Sclerosis Drug Gilenya (Fingolimod) Approved By FDA - QualityPoint Technologies
qualitypointtech.net — “Gilenya (fingolimod) 0.5 mg daily for the treatment of relapsing forms of multiple sclerosis has been approved by the Food and Drug Administration. Swiss pharmaceutical company, Novartis, says that Gilenya is the first oral medication indicated for relapsing forms of multiple sclerosis (MS) in the United States - it reduces the frequency of MS flare-up, as well as helping slow down the build-up of some of the physical problems associated with MS. Clinical trials involving 2,600 patients demonstr” View full resource at qualitypointtech.net
Most Recently Shared on September 22, 2010 at 7:12 pm By:
Multiple Sclerosis Drug Gilenya (Fingolimod) Approved By FDA: Gilenya (fingolimod) 0.5 mg daily for the treatment ... http://bit.ly/dxL7QD
Gilenya Approved for Relapsing MS - healthfinder.gov
healthfinder.gov — “Gilenya Approved for Relapsing MS - healthfinder.gov” View full resource at healthfinder.gov
Most Recently Shared on September 22, 2010 at 6:28 pm By:
Bruce McLucas, MD Doctor, ObGyn Physician, Surgeon, and Physician
Gilenya Approved for Relapsing MS - Oral drug designed to slow progressive disability http://ow.ly/197jVN
Novartis' Gilenya uptake to increase
news-medical.net — “A study published this week by ITG revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year. Gilenya came onto the market in late September as the first FDA-approved oral disease-modifying MS drug, and Novartis initially faced safety concerns and monitoring requirements that deterred some physicians from adopting the new drug.” View full resource at news-medical.net
Most Recently Shared on December 20, 2010 at 10:50 am By:
Novartis' Gilenya uptake to increase: A study published this week by ITG revealed that Novartis recently approve... http://bit.ly/i48uE6
MS "Pill" Approved - Multiple Sclerosis Blog
everydayhealth.com — “The first oral, disease-modifying MS drug, Fingolimod, was approved for release and marketing by the FDA's Advisory Committee.” View full resource at everydayhealth.com
Most Recently Shared on June 17, 2010 at 12:41 am By:
MS Blog Update: MS "Pill" Approved - The first oral, disease-modifying MS drug, Fingolimod, was approved for release... http://ht.ly/17LJc2
FDA Approves Novartis Multiple Sclerosis Drug - Forbes.com
forbes.com — “The Food and Drug Administration approves orally administered multiple sclerosis drug Gilenya.” View full resource at forbes.com
Most Recently Shared on September 22, 2010 at 8:07 pm By:
FDA Approves Novartis Multiple Sclerosis Drug: The Food and Drug Administration approves orally administered multi... http://bit.ly/cGeBVE
FDA Approves Novartis Multiple Sclerosis Drug - Forbes.com
forbes.com — “The Food and Drug Administration approves orally administered multiple sclerosis drug Gilenya.” View full resource at forbes.com
Most Recently Shared on September 22, 2010 at 8:02 pm By:
Drugs and Devices OW OW Health
FDA Approves Novartis Multiple Sclerosis Drug: The Food and Drug Administration approves orally administered ... http://bit.ly/9rmV81 #drug
FDA approves Gilenya capsules for reducing MS relapses
news-medical.net — “The U.S. Food and Drug Administration has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS).” View full resource at news-medical.net
Most Recently Shared on September 22, 2010 at 1:40 pm By:
FDA approves Gilenya capsules for reducing MS relapses: The U.S. Food and Drug Administration has approved Gilenya... http://bit.ly/cOWC1h
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
medical_tweets
Advertisement
